Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cantor Fitzgerald
Mallinckrodt
Boehringer Ingelheim
Fish and Richardson
Chubb
UBS
AstraZeneca
Cipla

Generated: June 20, 2018

DrugPatentWatch Database Preview

UNITENSEN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Unitensen, and what generic alternatives are available?

Unitensen is a drug marketed by Medpointe Pharm Hlc and is included in two NDAs.

The generic ingredient in UNITENSEN is cryptenamine tannates. Additional details are available on the cryptenamine tannates profile page.
Summary for UNITENSEN
US Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: 115
DailyMed Link:UNITENSEN at DailyMed
Drug patent expirations by year for UNITENSEN

US Patents and Regulatory Information for UNITENSEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc UNITENSEN cryptenamine acetates INJECTABLE;INJECTION 008814-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Medpointe Pharm Hlc UNITENSEN cryptenamine tannates TABLET;ORAL 009217-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fuji
Deloitte
Dow
Cerilliant
Queensland Health
Citi
Covington
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.